Our company specializes in developing innovative diagnostic tests for various medical conditions, including anosmia (loss of sense of smell), which is an early symptom of COVID-19. Our goal is to provide accurate and rapid diagnosis to help prevent the spread of the virus and improve patient outcome...See more
Headquarters:
United Kingdom of Great Britain and Northern Ireland
Company Type:
SME
Company size:
1-10 Employees
Address:
OXFORD, OXON OX3 9DL, GB
LOW
spending power